JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says

JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says

Submitted by admin on January 10, 2023 - 6:32pm
Source: 
Fierce Pharma
News Tags: 
JNJ
Horizon Therapeutics
M&A
Headline: 
JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says
snippet: 

In the recent battle for rare disease expert Horizon, Johnson & Johnson largely stuck to the background, CEO Joaquin Duato explained at this year’s J.P. Morgan Healthcare Conference.

Do Not Allow Advertisers to Use My Personal information